CME/CE from MPR


MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for myCME.com. See below for a list of each quarter's courses. Click here to visit MPR's website.




Latest Courses


MPR Drug News


CDC: Recommendations on the Use of Heplisav-B Published

Benefits of protection with 2 doses administered over 1 month make the vaccine an important option for prevention of HBV.

NDA Submitted for Postpartum Depression Treatment Brexanolone

Results in the 202B and 202C trials showed that brexanolone achieved the primary endpoint of mean reduction from baseline in the Hamilton Rating Scale for Depression.

MenB Vaccine Gets Breakthrough Tx Designation for Kids Ages 1 to 9 Years

The Breakthrough designation was based on data from Phase 2 studies which assessed the safety and efficacy of the vaccine in this patient population.

IBD and Anemia: Adverse Events After IV Iron Therapy Examined

To examine the occurrence of adverse reactions in this patient population, researchers from John Hopkins University, Baltimore, Maryland, conducted a retrospective analysis of IBD patients who received IV iron infusions between 2010 and 2014 in the commercial claims database, MarketScan.

First Test to ID Candida auris Gets FDA Approval

The Bruker Maldi system is already cleared for use in identifying 333 species or species groups, including 424 bacteria and yeast species.